丹娜生物
(920009)
| 流通市值：3.78亿 | | | 总市值：29.06亿 |
| 流通股本：1008.00万 | | | 总股本：7754.60万 |
| 利润表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 营业总收入 | 54,035,723.96 | 242,282,883.91 | 171,946,500 | 116,118,036.08 |
| 营业总成本 | 36,561,854.44 | 153,730,093.27 | - | 72,758,777.21 |
| 其他经营收益 | | | | |
| 营业利润 | 20,211,076.99 | 110,909,336.88 | 80,389,600 | 56,199,385.37 |
| 利润总额 | 20,209,916.62 | 110,665,027.84 | 80,158,900 | 56,099,135.35 |
| 净利润 | 18,321,517.76 | 97,742,993.21 | - | 49,964,916.32 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 18,321,517.76 | 97,742,993.21 | - | 49,964,916.32 |
| 资产负债表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 流动资产: | | | | |
| 流动资产合计 | 562,790,331.55 | 559,004,050.04 | - | 484,679,350.96 |
| 非流动资产: | | | | |
| 非流动资产合计 | 184,764,479.51 | 184,915,596.98 | - | 85,881,466.21 |
| 资产总计 | 747,554,811.06 | 743,919,647.02 | 592,796,100 | 570,560,817.17 |
| 流动负债: | | | | |
| 流动负债合计 | 41,230,026.86 | 55,554,257.04 | - | 43,929,110.91 |
| 非流动负债: | | | | |
| 非流动负债合计 | 10,173,792.57 | 10,668,691.22 | - | 12,148,697.01 |
| 负债合计 | 51,403,819.43 | 66,222,948.26 | 57,034,800 | 56,077,807.92 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 696,150,991.63 | 677,696,698.76 | 535,761,300 | 514,483,009.25 |
| 股东权益合计 | 696,150,991.63 | 677,696,698.76 | - | 514,483,009.25 |
| 负债和股东权益合计 | 747,554,811.06 | 743,919,647.02 | - | 570,560,817.17 |
| 现金流量表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 57,231,370.67 | 302,042,796.52 | - | 146,561,115.21 |
| 经营活动现金流出小计 | 58,412,142.25 | 195,459,950.7 | - | 95,513,234.52 |
| 经营活动产生的现金流量净额 | -1,180,771.58 | 106,582,845.82 | 60,935,100 | 51,047,880.69 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 442,990,860.72 | 3,038,695,678.24 | - | 1,894,844,565.03 |
| 投资活动现金流出小计 | 602,290,188.45 | 3,191,866,741.64 | - | 2,095,385,306.28 |
| 投资活动产生的现金流量净额 | -159,299,327.73 | -153,171,063.4 | - | -200,540,741.25 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | - | 136,800,000 | - | - |
| 筹资活动现金流出小计 | 0 | 20,893,926.25 | - | 5,704,088.26 |
| 筹资活动产生的现金流量净额 | 0 | 115,906,073.75 | - | -5,704,088.26 |
| 汇率变动对现金及现金等价物的影响 | -35,995.75 | -157,655.03 | - | -32,461.15 |
| 现金及现金等价物净增加额 | -160,516,095.06 | 69,160,201.14 | - | -155,229,409.97 |
| 期末现金及现金等价物余额 | 183,672,201.81 | 344,188,296.87 | - | 119,798,685.76 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | 69,160,201.14 | - | -155,229,409.97 |